1.Rosenthal, VD, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003–2008, issued June 2009. American Journal of Infection Control 2010; 38: 95–104 e102.
2.National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. American Journal of Infection Control 2004; 32: 470–485.
3.Davis, KA, et al. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clinical Infectious Diseases 2004; 39: 776–782.
4.Milstone, AM, et al. Methicillin-resistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission. Clinical Infectious Diseases 2011; 53: 853–859.
5.Calfee, DP, et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infection Control and Hospital Epidemiology 2008; 29 (Suppl. 1): S62–80.
6.Siegel, JD, et al. Management of multidrug-resistant organisms in healthcare settings. Atlanta, GA: Centers for Disease Control and Prevention, Department of Health and Human Services, USA, 2006.
7.King, MD, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Annals of Internal Medicine 2006; 144: 309–317.
8.Francis, JS, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clinical Infectious Diseases 2005; 40: 100–107.
9.Nakamura, MM, et al. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatric Infectious Disease Journal 2002; 21: 917–922.
10.Hussain, FM, Boyle-Vavra, S, Daum, RS. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatric Infectious Disease Journal 2001; 20: 763–767.
11.Cheng Immergluck, L, et al. Prevalence of Streptococcus pneumoniae and Staphylococcus aureus nasopharyngeal colonization in healthy children in the United States. Epidemiology and Infection 2004; 132: 159–166.
12.Fritz, SA, et al. Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus colonization in children seen in a practice-based research network. Pediatrics 2008; 121: 1090–1098.
13.Creech, CB 2nd, et al. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatric Infectious Disease Journal 2005; 24: 617–621.
14.Tenover, FC, et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. Journal of Clinical Microbiology 2006; 44: 108–118.
15.Otter, JA, French, GL. Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infectious Diseases 2006; 6: 753–755.
16.Patel, M, et al. USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections. Journal of Clinical Microbiology 2007; 45: 3431–3433.
17.Seybold, U, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clinical Infectious Diseases 2006; 42: 647–656.
18.Maree, CL, et al. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerging Infectious Diseases 2007; 13: 236–242.
19.Liu, C, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004–2005. Clinical Infectious Diseases 2008; 46: 1637–1646.
20.Klevens, RM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 2007; 298: 1763–1771.
21.McDougal, LK, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. Journal of Clinical Microbiology 2003; 41: 5113–5120.
22.Koreen, L, et al. spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. Journal of Clinical Microbiology 2004; 42: 792–799.
23.Harmsen, D, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. Journal of Clinical Microbiology 2003; 41: 5442–5448.
24.Shopsin, B, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. Journal of Clinical Microbiology 1999; 37: 3556–3563.
25.Carey, AJ, et al. Changes in the molecular epidemiological characteristics of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infection Control and Hospital Epidemiology 2010; 31: 613–619.
26.Popovich, K, et al. Phenotypic prediction rule for community-associated methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology 2007; 45: 2293–2295.
27.David, MD KA, et al. Community-associated methicillin-resistant Staphylococcusl aureus: nosocomial transmission in a neonatal unit. Journal of Hospital Infection 2006; 64: 244–250.
28.Healy, CM, et al. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clinical Infectious Diseases 2004; 39: 1460–1466.
29.McAdams, RM, et al. Spread of methicillin-resistant Staphylococcus aureus USA300 in a neonatal intensive care unit. Pediatrics International 2008; 50: 810–815.
30.Seybold, U, et al. Emergence of and risk factors for methicillin-resistant Staphylococcus aureus of community origin in intensive care nurseries. Pediatrics 2008; 122: 1039–1046.
31.Flayhart, D, et al. Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. Journal of Clinical Microbiology 2005; 43: 5536–5540.
32.Clinical and Laboratory Standards Institute. Performance standards for antimicrobials susceptibility testing; seventeenth informational supplement M100-S17 2007; 27: 1–182.
33.Oliveira, DC, de Lencastre, H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2002; 46: 2155–2161.
34.McClure, JA, et al. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci. Journal of Clinical Microbiology 2006; 44: 1141–1144.
35.Nair, N, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among patients admitted to adult intensive care units: The STAR*ICU Trial. Infection Control and Hospital Epidemiology 2011; 32: 1057–1063.
36.Milstone, AM, et al. Community-associated methicillin-resistant Staphylococcus aureus strains in pediatric intensive care unit. Emerging Infectious Diseases 2010; 16: 647–655.
37.Geva, A, et al. Spread of methicillin-resistant Staphylococcus aureus in a large tertiary NICU: network analysis. Pediatrics 2011; 128: e1173–1180.
38.Gerber, JS, et al. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clinical Infectious Diseases 2009; 49: 65–71.
39.Larsen, AR, et al. Two distinct clones of methicillin-resistant Staphylococcus aureus (MRSA) with the same USA300 pulsed-field gel electrophoresis profile: a potential pitfall for identification of USA300 community-associated MRSA. Journal of Clinical Microbiology 2009; 47: 3765–3768.
40.Huskins, WC, et al. Intervention to reduce transmission of resistant bacteria in intensive care. New England Journal of Medicine 2011; 364: 1407–1418.
41.Jain, R, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. New England Journal of Medicine 2011; 364: 1419–1430.
42.Gorwitz, RJ. Understanding the success of methicillin-resistant Staphylococcus aureus strains causing epidemic disease in the community. Journal of Infectious Diseases 2008;197: 179–182.